298 filings
6-K
IMRN
Immuron Limited
23 Apr 24
Report of Foreign Private Issuer
6:06am
6-K
IMRN
Immuron Limited
15 Apr 24
Report of Foreign Private Issuer
8:00am
6-K
IMRN
Immuron Limited
10 Apr 24
Immuron Travelan® sales continued strong growth
6:14am
6-K
IMRN
Immuron Limited
14 Mar 24
Report of Foreign Private Issuer
6:50am
6-K
IMRN
Immuron Limited
7 Mar 24
Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
8:00am
6-K
zrbaddo1sg amqy
4 Mar 24
Report of Foreign Private Issuer
9:19pm
6-K
pj52 wzau5c6l
28 Feb 24
Results for announcement to the market
8:08am
6-K
xr3zk1n1udoyx717sf83
21 Feb 24
Report of Foreign Private Issuer
8:00am
6-K
ntdorbvo
13 Feb 24
Immuron achieves record Travelan® sales
8:00am
6-K
x1jfi7tt20g7 g9roy
9 Feb 24
Investor Webinar Presentation
12:00am
6-K
wdqlqki
16 Jan 24
Immuron achieves record half yearly Travelan® sales
8:00am
6-K
svkzzg9hv1
22 Dec 23
Immuron Clinical Trials Update
7:21am
6-K
kts2yrw6wd rg8
4 Dec 23
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study
6:32am
6-K
5by3h0dn
28 Nov 23
Investor Webinar Presentation
6:17am
6-K
e2q2c6xy7oku
22 Nov 23
Report of Foreign Private Issuer
7:16am
6-K
sxz3hfjycbmkub231t
21 Nov 23
Report of Foreign Private Issuer
6:05am
6-K
ecex2pcarmd
13 Nov 23
Investor Webinar Presentation
8:28am
6-K
84sfrrj1k 2yl
30 Oct 23
Immuron CEO, Steven Lydeamore to present at AusBioInvest
8:00am
6-K
rgk q380srl
23 Oct 23
Notice of 2023 Annual General Meeting and 21 November 2023 at 10.00 am
8:00am
6-K
kt7do6794g9jzm
18 Oct 23
Report of Foreign Private Issuer
6:05am